Camargo Pharmaceutical Services
10151 Carver Road
Suite 200
Cincinnati
Ohio
45242
United States
Tel: 513-561-3329
Fax: 513-561-3367
Website: http://www.camargopharma.com/
Email: camargo@camargopharma.com
51 articles about Camargo Pharmaceutical Services
-
Premier Research Acquires Camargo Pharmaceutical Services
5/18/2021
Premier Research announced that it has acquired Camargo Pharmaceutical Services based in Cincinnati.
-
Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for Cancer Patients
2/8/2021
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company , today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the Investigational New Drug application
-
Reeves McGee Appointed Chief Commercial Officer at Camargo Pharmaceutical Services, LLC
10/13/2020
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Reeves McGee as Chief Commercial Officer. In this senior leadership role, McGee will oversee the development and implementation of Camargo's commercial strategies, its commercial organic growth initiatives and the
-
Jennie Orr Appointed Chief Strategy and Business Officer at Camargo Pharmaceutical Services, LLC
10/13/2020
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced the appointment of Jennie Orr as Chief Strategy and Business Officer.
-
Robb Lawrence Appointed Vice President of Commercial Strategy at Camargo Pharmaceutical Services, LLC
8/31/2020
Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Robb Lawrence as Vice President of Commercial Strategy. In this senior leadership role, Lawrence will lead the design and development of strategic solutions that optimize patient access and outcomes by navigating the
-
Camargo client Chiasma receives FDA approval for first and only oral somatostatin analog for long-term maintenance treatment of acromegaly
7/2/2020
Camargo Pharmaceutical Services, LLC, congratulates Chiasma, Inc. on obtaining approval from the US Food and Drug Administration for MYCAPSSA® (octreotide) capsules. MYCAPSSA is the first and only oral somatostatin analog (SSA) approved by the FDA.
-
Camargo Pharmaceutical Services Enhances Drug Development Services Through Acquisition of Montreal-based InSymbiosis
6/13/2019
Acquisition strengthens integrated drug development solution and expands global footprint
-
Cellix Biosciences Completes Pre-IND Meeting with FDA on CLX-103 for Ulcerative Colitis
10/29/2018
Cellix Biosciences Inc. today announced successful completion of a Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA).
-
Camargo Congratulates US WorldMeds on Obtaining FDA Approval for the First Non-Opioid Medicine for the Management of Opioid Withdrawal Symptoms
7/9/2018
Camargo Pharmaceutical Services, LLC congratulates US WorldMeds, LLC, on obtaining US Food and Drug Administration (FDA) approval for LUCEMYRA™ (lofexidine) tablets
-
Camargo Celebrates Fifteen Years
6/1/2018
June 1, 2018 marks the 15th anniversary for Camargo Pharmaceutical Services, LLC, ("Camargo").
-
Daniel S. Duffy - Appointed New CEO of Camargo Pharmaceutical Services, LLC
4/30/2018
Camargo Pharmaceutical Services, LLC, announced the appointment of Daniel S. Duffy as new Chief Executive Officer.
-
V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of Transformative Prodrug Technology Platform
3/6/2018
Camargo will provide end-to-end regulatory consulting and strategic development services.
-
Lumosa Partners With Camargo Pharmaceutical Services In The Development Of Naldebain In The U.S.
8/28/2017
-
Cingulate Partners With Camargo Pharmaceutical Services For Development Programs
8/8/2017
-
Quivive Pharma Partners With Camargo Pharmaceutical Services For Development Programs
5/4/2017
-
Camargo Pharmaceutical Services Partners With Private Investment Firm
3/16/2017
-
Impel NeuroPharma Partners With Camargo Pharmaceutical Services For Development Programs
2/7/2017
-
Cocoon Biotech Announces Partnership With Camargo Pharmaceutical Services For Development Programs
2/2/2017
-
Camargo Pharmaceutical Services Adds To Medical Device Expertise
9/28/2016
-
Medicines360 and Camargo Pharmaceutical Services Gain FDA Approval for Intrauterine Contraceptive Device
1/19/2016